Hepatic stellate cells induce hepatocellular carcinoma cell resistance to sorafenib through the laminin‐332/α3 integrin axis recovery of focal adhesion kinase ubiquitination

Amalia Azzariti(Istituto Tumori Bari), Gianluigi Giannelli(Gastroenterology Hospital "Saverio de Bellis")

Hepatology

September 17, 2016

10.1002/hep.28835

Cited by 102

Related Papers

Role of epithelial to mesenchymal transition in hepatocellular carcinoma

|Journal of Hepatology|2016|641

Circulating extracellular vesicles expressing PD1 and PD-L1 predict response and mediate resistance to checkpoint inhibitors immunotherapy in metastatic melanoma

|Molecular Cancer|2022|147

Targeting transforming growth factor (TGF)‐βRI inhibits activation of β1 integrin and blocks vascular invasion in hepatocellular carcinoma†

|Hepatology|2008|140

Differential Inhibition of the TGF-β Signaling Pathway in HCC Cells Using the Small Molecule Inhibitor LY2157299 and the D10 Monoclonal Antibody against TGF-β Receptor Type II

|PLoS ONE|2013|94

Laminin-5 stimulates hepatocellular carcinoma growth through a different function of α6β4 and α3β1 integrins

|Hepatology|2007|71